Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1991

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Oral contraceptives and neoplasia of the ovary.

AUTHORS

Stanford JL

SOURCE

CONTRACEPTION. 1991 Jun;43(6):543-56.

ABSTRACT

Epidemiologic literature on oral contraceptives (OCs) in relation to primary ovarian cancer is reviewed. Compared to

women who had never used OCs, women who have taken them have found a 30% reduction in risk for epithelial

ovarian cancer; 5 or more years of use is associated with a 50% reduction in risk. The protective effect of OCs

persists for 10 or more years after discontinuation of use and becomes apparent several years after initiation of use.

Effects of OCs are similar for malignant and borderline malignant epithelial ovarian cancer. Reduced risks among

OC users have been observed for all major histologic subtypes of epithelial ovarian cancer, and for women from

developed and developing countries. Risk estimates for epithelial ovarian cancer in relation to OC use stratified by

age at diagnosis or parity are not uniform across studies. No consistent protective effect is apparent for

nonepithelial ovarian tumors or benign ovarian tumors, including teratomas and cystadenomas, although limited data

are available on the relationship between OCs and these neoplasms. Several areas for future research are

described. (author's) (PubHealth.info Document ID: CONT3T 2002-06)

PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives and neoplasia of the ovary.", is(are)

Stanford JL. The source of this article is "CONTRACEPTION. 1991 Jun;43(6):543-56.". This article was published in

1991 in English language(s). (PubHealth.info® Document ID: CONT3T 2002-06. All rights reserved with

PubHealth.info) PIN: 12002

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.